Immunotec Announces First Quarter 2013 Financial Results
Revenue increases by 10% and strong net profit
(firmenpresse) - VAUDREUIL-DORION, QUEBEC -- (Marketwire) -- 03/21/13 -- Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Company" or "Immunotec"), today released its first quarter 2013 financial results for the three-month period ended 31 January 2013.
"As the Company continues to execute against our business plan, we have delivered a strong quarter with net profit of $528 thousand. These results represent the best quarter we have seen in six years. Our profitability has improved and we continue to lay the groundwork for a strong future." said Bob Henry, Immunotec's Chairman and CEO.
Highlights for the first quarter of fiscal 2013
(1) Refer to "Adjusted EBITDA" in the non-GAAP financial measures section of Management's Discussion and Analysis for the three-month period ended 31 January 2013.
About Immunotec Inc.
Immunotec is a world-class business opportunity supported by unique, scientifically proven products that improve wellness. Headquartered with manufacturing facilities near Montreal, Canada, the Company also has distribution capacities to support its commercial activities in Canada and internationally to the United States, Europe, Mexico and the Caribbean.
The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at and on the Company's website at . The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at . Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.
Contacts:
Patrick Montpetit
Chief Financial Officer
(450) 510-4527
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 21.03.2013 - 18:00 Uhr
Sprache: Deutsch
News-ID 242039
Anzahl Zeichen: 0
contact information:
Town:
VAUDREUIL-DORION, QUEBEC
Kategorie:
Health & Nutrition
Diese Pressemitteilung wurde bisher 183 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Immunotec Announces First Quarter 2013 Financial Results"
steht unter der journalistisch-redaktionellen Verantwortung von
Immunotec Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
